Target intelligence / Profile preview

Leucine-rich repeat-containing protein 37B (LRRC37B)

Target
LRRC37B
Molecular classification
Single-pass transmembrane protein, Co-receptor, Leucine-rich repeat (LRR)-containing family, Other
01

Overview

LRRC37B is a member of the primate-specific LRRC37 family, typically found as a single-pass membrane protein with an extensive leucine-rich repeat extracellular domain. The LRR domain is crucial for binding proteins and is necessary/sufficient for binding its identified ligand FGF13A. LRRC37B acts as a co-receptor for extracellular secreted FGF13A, and this interaction inhibits the function of voltage-gated sodium channels (specifically Nav1.6) in neurons. This localization and function suggest a potential role in modulating neuronal excitability and possibly influencing neurodevelopmental processes. LRRC37B is also found on human chromosome 17q11, a region subject to frequent genomic rearrangements and duplications, which may confer susceptibility to certain genetic disorders, though the specific implications of LRRC37B in pathology remain largely uncharacterized. No drugs or established biomarkers are currently associated with LRRC37B, and its clinical significance is not yet defined.

Other names
LRRC37BLeucine-rich repeat-containing protein 37BC66 SLIT-like testicular proteinKIAA0563-relatedLRRC37
02

Mechanism of action

Modulates sodium channel activity via interaction with FGF13A; Acts as a co-receptor for FGF13A; affects neuronal excitability by locally regulating FGF13A and Nav1.6 at the axon initial segment

03

Biological functions

Protein-protein interaction via LRR motifsModulation of voltage-gated sodium channel function (Nav channels) through interaction with FGF13ACell signaling and growth regulatory processes (highly speculative, based on family associations)
04

Disease associations

Neurodevelopmental roles—expression in cortex, implicated in sodium channel modulationGenomic rearrangements associated with disease susceptibility (e.g., neurofibromatosis type 1 locus)Other
05

Safety considerations

No direct safety datapossible gene rearrangements in chromosome 17q11 are associated with disease susceptibilityunknown if LRRC37B itself presents direct safety issues

Beyond the preview

Go deeper on Leucine-rich repeat-containing protein 37B (LRRC37B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leucine-rich repeat-containing protein 37B (LRRC37B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call